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The Research foundation of the Region of Southern Denmark; Kraeftens Bekaempelse; Odense Universitetshospital; Syddansk Universitet Background and Objectives: The measurement of tumor regression after neoadjuvant oncological treatment has gained increasing interest because it has a prognostic value and because it may influence the method of treatment in rectal cancer. The assessment of tumor regression remains difficult and inaccurate with existing methods. Dual Energy Computed Tomography (DECT) enables qualitative tissue differentiation by simultaneous scanning with different levels of energy. We aimed to assess the feasibility of DECT in quantifying tumor response to neoadjuvant therapy in loco-advanced rectal cancer.
Methods:
We enrolled 11 patients with histological and MRI verified loco-advanced rectal adenocarcinoma and followed up on them prospectively. All patients had one DECT scanning before neoadjuvant treatment and one 12 weeks after using the spectral imaging scan mode. DECT analyzing tools were used to determine the average quantitative parameters; effective-Z, water-and iodine-concentration, Dual Energy Index (DEI), and Dual Energy Ratio (DER). These parameters were compared to the regression in the resection specimen as measured by the pathologist.
Results: Changes in the quantitative parameters differed significantly after treatment in comparison with pre-treatment, and the results were different in patients with different CRT response rates.
Conclusion: DECT might be helpful in the assessment of rectal cancer regression grade after neoadjuvant treatment.
Neoadjuvant chemo-radiotherapy (nCRT) given to patients with locally advanced rectal cancer improves local disease control after radical surgery and leads to variable degrees of tumor down staging. 1 Fifteen to twenty percent of the patients who undergo nCRT have a histo-pathological complete response (pCR) after 8-12 weeks in which no residual cancer is reported at histological examination of the resection specimen. 2 A pCR following nCRT is associated with excellent long-term survival with low rates of local recurrence and metastasis making it an independent predictor of prognosis.
2
Patients with comorbidity may benefit in terms of treatmentrelated morbidity and mortality from avoiding major rectal resections.
Ongoing trials indicate that watchful waiting may become an option for As demonstrated in earlier studies, simultaneous scanning with two x-ray beams with variable energy levels (DECT) allows for differentiation between benign and malignant tissue. 7 By scanning with varying energy levels, the patients can be exposed to a lower radiation dose using DECT compared to regular CT. completing CRT (12 weeks after the initiation of nCRT). TME was made 2-4 weeks after the follow-up MRI and DECT scan. The images were analyzed with integrated imaging analytic tools for quantitative assessment of the iodine and water concentration, effective-z, dual energy index, and the dual energy ratio (See Fig. 1 ).
| Dual energy CT
A dedicated radiologist applied three circular regions of interest on each tumor on all DECT-scanning images. The three chosen ROIs were based on a macroscopic evaluation of the most representative images of the associated MRI scan.
| Histopathology
A dedicated pathologist assessed the RCRG after resection and scored the tumor according to 5 RCRG levels. 
| Statistics
The differences in the quantitative parameters within the different RCRG groups are given as means and standard deviations. An F-test is used to test the differences in means before and after chemo-radiation stratified to different RCRG groups, with a null hypothesis of equality.
A P value of <0.05 was regarded as significant.
3 | RESULTS
| Diagnostic performance of the quantitative parameters
Within the feasibility settings of this study, we aimed to determine the best quantitative unique DECT parameter for further assessment of AL-NAJAMI ET AL.
| 985 the RCRG. As illustrated in Table 1 and Fig. 2 , changes of the effective Z value was consistently correlated to the different RCRG groups. The change in the other parameters was similar to that of effective Z, but in a less consistent manner, and with larger standard deviations ( Table 1) .
Only the effective Z value showed a high degree of correlation to the respective RCRG group with a correlation coefficient r 2 = 0.96, making it the parameter of choice in this study.
Eleven patients were enrolled in the study. Extracted and calculated data from the Regions of interest were analyzed and the change within each response group from before and after treatment is shown in Table 1 . The pathology results consisted of two complete responders, six partial responders, and three non-responders.
| The effective Z pre-and post CRT compared to CRT response
The mean effective Z of the pre-CRT DECT scans of all the enrolled patients was 8.82 (see Table 1 ).
In relation to the complete responders the mean effective Z value was 8.31. Compared to the effective Z value pre-CRT there was a decrease of 7.0% (P < 0.05). For the partial responders the mean effective Z value was 8.59 compared to the effective Z value obtained before treatment corresponding to a decrease of 3% (P < 0.05). In the group of non-responders there was no significant change in the effective-z. The mean value was 8.83 compared to the pre-CRT effective Z value and we obtained a change of 0.3% (P > 0.05). See
Figs. 3 and 4, Table 1 .
We demonstrated a 6% decrease in the effective Z post CRT for complete responders (8.31) compared to non-responders (8.83).
| DISCUSSION
The aim of this feasibility study was to investigate whether DECT could measure and perhaps quantify the tumor regression grade in patients with loco-advanced rectal cancer by comparing DECT scanning before and after neoadjuvant treatment. We also compared the DECT unique effective Z post CRT in patients with different response to nCRT to assess the difference in the tumor regression grade.
The assessment of tumor regression is today based on a specific dedication to rectal cancer staging imaging. This imaging is often prone to the imaging modality dedication and the results of the staging are often operator dependent. One advantage of DECT is that it would be suitable for all centers and also less dedicated MRI centers dealing with rectal cancer as the technique does not require investment in costly equipment but can be added to regular clinical CT scanners by software installation. It also has the potential of decreasing operator dependency by measuring objective quantitative parameters.
As shown in Table 1 , all parameters in RCRG 1 had reduced values except for the water concentration parameter. As expected, the largest changes in the quantitative parameters were observed in the group with the highest regression grade. It is of interest that the changes were seen both in the measurements of the material composition being When looking at Fig. 2 and Table 1 we see a variation within each RCRG for DER, DEI and iodine measurements, and a wide range in the standard deviations suggesting a random distribution in each response group. Our study suggests that the effective-z could be used as an indicator to differentiate between a complete response and a no response in rectal cancer. However, the low number of subjects in this study does not allow for the exclusion of any of the other parameters in the quantification of tumor response to nCRT.
By observing a difference in the post CRT values of the effective Z value stratified in the different CRT response group we may be able to facilitate better allocation of patients to the most appropriate treatment. It might also facilitate more prompt surgical treatment to poor responders since they would not continue to experience tumor regression as would be the case with some of the partial responders.
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Our results reveal a clear difference in the z-value between complete, partial, and non-responders. However, the number of patients included in this study is too small to conclude that we can reproducibly differentiate between different degrees of partial response. A larger study is needed and it is in preparation.
| CONCLUSIONS
This study is the first to evaluate the utility of DECT in measuring tumor response to nCRT in rectal cancer. Our preliminary data indicates that the effective-Z value might enable identifying and possibly quantifying pathological response.
DECTs clinical applicability must be preceded by a comparison to gold standard in the assessment of rectal tumor regression being MRI. https://doi.org/10.1002/jso.24761
FIGURE 4
Illustrates the increase in effective Z with the decreasing response to chemo radiation therapy, by comparing the effective Z before chemo radiation therapy (pre-CRT) to the three different rates of response
